Cordatus Wealth Management LLC Invests $575,000 in Relx Plc (NYSE:RELX)

Key Points

• Cordatus Wealth Management LLC purchased 11,399 shares of Relx Plc valued at approximately $575,000 as reported in their latest SEC filing.
• Multiple institutional investors, including Commonwealth Equity Services LLC and LPL Financial LLC, have recently increased their stakes in Relx, indicating growing investor interest.
• Relx has announced a semi-annual dividend of $0.2634, reflecting a dividend yield of 1.7% and a payout ratio of 65.05%.

Cordatus Wealth Management LLC purchased a new position in shares of Relx Plc (NYSE:RELX - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 11,399 shares of the technology company's stock, valued at approximately $575,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Larson Financial Group LLC raised its position in Relx by 612.5% in the 1st quarter. Larson Financial Group LLC now owns 513 shares of the technology company's stock worth $26,000 after purchasing an additional 441 shares during the last quarter. Golden State Wealth Management LLC grew its holdings in shares of Relx by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 588 shares of the technology company's stock valued at $30,000 after buying an additional 294 shares during the period. Cornerstone Planning Group LLC raised its stake in Relx by 325.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 693 shares of the technology company's stock worth $37,000 after buying an additional 530 shares during the period. Transce3nd LLC acquired a new position in Relx in the fourth quarter valued at about $40,000. Finally, Brown Brothers Harriman & Co. increased its holdings in shares of Relx by 218.5% in the fourth quarter. Brown Brothers Harriman & Co. now owns 965 shares of the technology company's stock worth $44,000 after acquiring an additional 662 shares in the last quarter. Institutional investors own 15.02% of the company's stock.

Relx Stock Up 0.2%

NYSE:RELX traded up $0.13 during trading hours on Monday, reaching $51.72. 515,853 shares of the stock were exchanged, compared to its average volume of 795,122. The stock has a market cap of $94.99 billion, a PE ratio of 27.81, a PEG ratio of 3.36 and a beta of 0.88. Relx Plc has a twelve month low of $43.45 and a twelve month high of $56.33. The firm has a 50 day moving average of $53.31 and a 200 day moving average of $51.59. The company has a debt-to-equity ratio of 2.55, a current ratio of 0.47 and a quick ratio of 0.42.

Relx Cuts Dividend

The business also recently declared a semi-annual dividend, which will be paid on Tuesday, September 16th. Shareholders of record on Friday, August 8th will be paid a $0.2634 dividend. This represents a yield of 170.0%. The ex-dividend date is Friday, August 8th. Relx's dividend payout ratio (DPR) is currently 65.05%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Wall Street Zen raised Relx from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. Morgan Stanley reissued an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. Five analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy".

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.